1Bertolini G,Aquino M,Biffi M,et al. Leflunomide,an immunorestoring drug for the therapy of autoinnune disorders, especially rheumatoid arthritis [ J ]. Transplant Proc,1996,28: 3074 - 3078. 被引量：1
2Giorgio B, Mario A, Mauro B, et al. A new rational hypothsis for the phamacophore of the active metabolite of leflunomide, a potent immunosuppressive drug [ J ]. J Med Chem, 1997,40(13) :2011 - 2016. 被引量：1
3Hiroyuki yasuda. Syntheses of 4,5 - disubstitutedisoxazoles and their cleavage reaction with sodium ethoxide. Yakugaku Zasshi 1959,79(6) :836 - 838. 被引量：1
4Hiroyuki Y. Studies on the synthesis of 4,5-disubstituted isaoxazoles and their cleavage reaction with sodium ethoxide III. Structure of isoxazole compound derived from ethyl 2- formylacetoacetate[J]. Yakugaku Zasshi, 1959,79(6): 836-838. 被引量：1
5Doleshall G, Seres R Isoxazole-oxazole conversion by Beckmann rearrangement[J]. J Chem Soc, Perkin Trans I, 1988(7): 1875- 1879. 被引量：1
6Giulia M,Lusia M,Pitero S. Reaction of 2-dimethylaminomethylene-1,3-diones with dinucleophiles VI. Synthesis of ethyl or methyl 1,5-disubstituted 1H-pyrazole--4-carboxylates [J]. J Heterocyclic Chem, 1987,24: 1669-1675. 被引量：1
7Gallagher P T, Hicks T A, Mullier G W. N-Phenyl butenamides with pharmaceutical properties: EP, 0257882 [P].1988-03-02. 被引量：1
8Masaaki T, Noriyoshi H. Production of alkyl 2-ethoxymeihyleneacetoacetate: JP,3106849[P]. 1991-05-07. 被引量：1
9Ramakrishinan A,Gobind K,Neeraj K, et al. An improved process for preparation of leflunomide: WO,2007086076[P]. 2007 -08 -02. 被引量：1
10Eser F, Bodur H and Aktekin L A. , et al. Evaluation of effectiveness of leflunomide in the treatment of rheumatoid arthritis [ J ]. Romatizma - Rheumatism. 2008, 23 ( 2 ) : 52 - 55. 被引量：1
